Cargando…

Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?

PURPOSE: Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy (SBRT) for pancreatic adenocarcinoma (PDAC). While on-board imaging for fiducial matching allows for daily shifts to optimize target pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Colin S., Han-Oh, Sarah, Cheng, Zhi, Wang, Ken Kang-Hsin, Meyer, Jeffrey J., Herman, Joseph M., Narang, Amol K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980583/
https://www.ncbi.nlm.nih.gov/pubmed/33741015
http://dx.doi.org/10.1186/s13014-021-01782-w
_version_ 1783667457416757248
author Hill, Colin S.
Han-Oh, Sarah
Cheng, Zhi
Wang, Ken Kang-Hsin
Meyer, Jeffrey J.
Herman, Joseph M.
Narang, Amol K.
author_facet Hill, Colin S.
Han-Oh, Sarah
Cheng, Zhi
Wang, Ken Kang-Hsin
Meyer, Jeffrey J.
Herman, Joseph M.
Narang, Amol K.
author_sort Hill, Colin S.
collection PubMed
description PURPOSE: Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy (SBRT) for pancreatic adenocarcinoma (PDAC). While on-board imaging for fiducial matching allows for daily shifts to optimize target positioning, the magnitude of the shift as a result of inter- and intra-fraction variation may directly impact target coverage and dose to organs-at-risk. Herein, we characterize the variation patterns for PDAC patients treated at a high-volume institution with SBRT. METHODS: We reviewed 30 consecutive patients who received SBRT using active breathing coordination (ABC). Patients were aligned to bone and then subsequently shifted to fiducials. Inter-fraction and intra-fraction scans were reviewed to quantify the mean and maximum shift along each axis, and the shift magnitude. A linear regression model was conducted to investigate the relationship between the inter- and intra-fraction shifts. RESULTS: The mean inter-fraction shift in the LR, AP, and SI axes was 3.1 ± 1.8 mm, 2.9 ± 1.7 mm, and 3.5 ± 2.2 mm, respectively, and the mean vector shift was 6.4 ± 2.3 mm. The mean intra-fraction shift in the LR, AP, and SI directions were 2.0 ± 0.9 mm, 2.0 ± 1.3 mm, and 2.3 ± 1.4 mm, respectively, and the mean vector shift was 4.3 ± 1.8 mm. A linear regression model showed a significant relationship between the inter- and intra-fraction shift in the AP and SI axis and the shift magnitude. CONCLUSIONS: Clinically significant inter- and intra-fraction variation occurs during treatment of PDAC with SBRT even with a comprehensive motion management strategy that utilizes ABC. Future studies to investigate how these variations could lead to variation in the dose to the target and OAR should be investigated. Strategies to mitigate the dosimetric impact, including real time imaging and adaptive therapy, in select cases should be considered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-021-01782-w.
format Online
Article
Text
id pubmed-7980583
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79805832021-03-22 Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy? Hill, Colin S. Han-Oh, Sarah Cheng, Zhi Wang, Ken Kang-Hsin Meyer, Jeffrey J. Herman, Joseph M. Narang, Amol K. Radiat Oncol Research PURPOSE: Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy (SBRT) for pancreatic adenocarcinoma (PDAC). While on-board imaging for fiducial matching allows for daily shifts to optimize target positioning, the magnitude of the shift as a result of inter- and intra-fraction variation may directly impact target coverage and dose to organs-at-risk. Herein, we characterize the variation patterns for PDAC patients treated at a high-volume institution with SBRT. METHODS: We reviewed 30 consecutive patients who received SBRT using active breathing coordination (ABC). Patients were aligned to bone and then subsequently shifted to fiducials. Inter-fraction and intra-fraction scans were reviewed to quantify the mean and maximum shift along each axis, and the shift magnitude. A linear regression model was conducted to investigate the relationship between the inter- and intra-fraction shifts. RESULTS: The mean inter-fraction shift in the LR, AP, and SI axes was 3.1 ± 1.8 mm, 2.9 ± 1.7 mm, and 3.5 ± 2.2 mm, respectively, and the mean vector shift was 6.4 ± 2.3 mm. The mean intra-fraction shift in the LR, AP, and SI directions were 2.0 ± 0.9 mm, 2.0 ± 1.3 mm, and 2.3 ± 1.4 mm, respectively, and the mean vector shift was 4.3 ± 1.8 mm. A linear regression model showed a significant relationship between the inter- and intra-fraction shift in the AP and SI axis and the shift magnitude. CONCLUSIONS: Clinically significant inter- and intra-fraction variation occurs during treatment of PDAC with SBRT even with a comprehensive motion management strategy that utilizes ABC. Future studies to investigate how these variations could lead to variation in the dose to the target and OAR should be investigated. Strategies to mitigate the dosimetric impact, including real time imaging and adaptive therapy, in select cases should be considered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-021-01782-w. BioMed Central 2021-03-19 /pmc/articles/PMC7980583/ /pubmed/33741015 http://dx.doi.org/10.1186/s13014-021-01782-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hill, Colin S.
Han-Oh, Sarah
Cheng, Zhi
Wang, Ken Kang-Hsin
Meyer, Jeffrey J.
Herman, Joseph M.
Narang, Amol K.
Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
title Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
title_full Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
title_fullStr Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
title_full_unstemmed Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
title_short Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
title_sort fiducial-based image-guided sbrt for pancreatic adenocarcinoma: does inter-and intra-fraction treatment variation warrant adaptive therapy?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980583/
https://www.ncbi.nlm.nih.gov/pubmed/33741015
http://dx.doi.org/10.1186/s13014-021-01782-w
work_keys_str_mv AT hillcolins fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy
AT hanohsarah fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy
AT chengzhi fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy
AT wangkenkanghsin fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy
AT meyerjeffreyj fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy
AT hermanjosephm fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy
AT narangamolk fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy